Markets

Checking Out the Fundamental Data for Pain Therapeutics, Inc. (PTIE)

Pain Therapeutics, Inc. (NASDAQ:PTIE) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market value of 61.22M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Pain Therapeutics, Inc. (NASDAQ:PTIE) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For PTIE, the company currently has 11.92 million of cash on the books. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 12.38 million in total assets, balanced by 1.01 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Pain Therapeutics, Inc. (PTIE) saw -2.15 million in free cash flow last quarter, representing a quarterly net change in cash of -2.15 million. Perhaps most importantly where cash movements are concerned, the company saw about -2.15 million in net operating cash flow.



Pain Therapeutics, Inc. (NASDAQ:PTIE) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost.  That represents a quarterly year/year change in revenues of 0.00 in sequential terms, the PTIE saw sales decline by 0.00.

But what about the bottom line? After all, that’s what really matters in the end. Pain Therapeutics, Inc. (PTIE) is intriguing when broken down to its core data. The cost of selling goods last quarter was 17,000, yielding a gross basic income of -17,000 . For shareholders, given the total diluted outstanding shares of 6.54 million, this means overall earnings per share of -0.40.




Is Pain Therapeutics, Inc. (NASDAQ:PTIE) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about -2.6 in total earnings per share. If One should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Pain Therapeutics, Inc..

Previous ArticleNext Article

Related Post

LendingClub Corporation (LC) Raising Eyebrows Amon... LendingClub Corporation (NYSE:LC) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market valu...
ImmunoCellular Therapeutics, Ltd. (IMUC): Signals ... ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) gained 10.78% in yesterday’s session, going up from its prior closing price of $0.33 to $0.37. The price...
Taking a Look at the Operational Data for Nokia Co... Nokia Corporation (NYSE:NOK) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trad...
How Does the Fundamental Picture Look for Goldcorp... Goldcorp Inc. (NYSE:GG) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading ...
It’s worth it to have a look at Top Ships In... Top Ships Inc. (NASDAQ:TOPS) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a market value o...